Manually Assisted Cough Technique and Incomplete Cervical Spine Injury
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04741126 |
Recruitment Status :
Completed
First Posted : February 5, 2021
Last Update Posted : December 15, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Spinal Cord Injuries | Other: Manually assisted cough technique | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 28 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Effectiveness of the Manually Assisted Cough Technique on Peak Coughs Flow and Pulmonary Functions in Patients With Incomplete Cervical Spine Injury |
Actual Study Start Date : | November 1, 2020 |
Actual Primary Completion Date : | August 1, 2021 |
Actual Study Completion Date : | August 1, 2021 |

Arm | Intervention/treatment |
---|---|
Experimental: Intervention Protocol
Hospital-based manually assisted cough technique for 4 weeks.
|
Other: Manually assisted cough technique
Manually assisted cough technique will be given for four weeks. 10 to 12 repetitions of manually assisted cough technique with rest will be given in one minute 3 to 4 time of repetition in a 1 set. The result of the peak cough flow meter and incentive spirometer will be check pre and post only.3 sets will be given in one session and 2-time session will be recommended per day. The session will be given three days in a week. The Result of the Peak Cough flow meter and incentive spirometer will be check pre and post only. |
- Peak cough flow [ Time Frame: 4 weeks ]Changes from the baseline will be measured after 4 weeks through a small, hand-held device which is used to monitor a person's ability to breathe out air. It measures the airflow through the bronchi of the lungs and thus indicates the degree of obstruction in the airways. Peak flow readings are higher health airways and decreases in obstructive airways.
- Pulmonary functions [ Time Frame: 4 weeks ]Changes from the baseline will be measured after 4 weeks through the incentive spirometer. This device will measure how deeply patient can inhale (breathe in) and to evaluate the volumes and capacities of the patient before and after intervention.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 25 Years to 40 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- The patient with incomplete cervical spine injury at C4, C5,
- bronchitis,
- shortness of breath having Peak cough flow (PCF) less than 50% and
- ASIA impairment scale C &D
Exclusion Criteria:
- The patient with upper cervical,
- thoracic, and
- lumbar spine injury,
- diagnosed with TB,
- degenerative diseases,
- surgical conditions, and
- complete spinal cord injury.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04741126
Pakistan | |
Paraplegic center Peshawar. | |
Peshawar, KPK, Pakistan, 25000 |
Principal Investigator: | Mehwish Waseem, MSPT(CPPT) | Riphah International University |
Responsible Party: | Riphah International University |
ClinicalTrials.gov Identifier: | NCT04741126 |
Other Study ID Numbers: |
Rec/00782 Nadeem Ahmad |
First Posted: | February 5, 2021 Key Record Dates |
Last Update Posted: | December 15, 2021 |
Last Verified: | December 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Manually assisted cough technique Peak cough flow Pulmonary function Spinal cord injury |
Cough Spinal Cord Injuries Wounds and Injuries Spinal Cord Diseases Central Nervous System Diseases |
Nervous System Diseases Trauma, Nervous System Respiration Disorders Respiratory Tract Diseases Signs and Symptoms, Respiratory |